title: Effects of brefeldin A on the endocytic route. Redistribution of mannose 6-phosphate/insulin-like growth factor II receptors to the cell surface.
abstract: The effect of brefeldin A (BFA) on the trafficking of the mannose 6-phosphate/insulin-like growth factor II receptor within the endocytic route was analyzed. Treatment with BFA induced a redistribution of the receptor to the cell surface and increased both the binding and internalization of ligands 2-4-fold. The effect of BFA was dose- and time-dependent and reversible. Determinations of transport rates showed that BFA increases the internalization rate and the externalization rate of the receptor. This implies that the higher surface concentration is due to higher concentrations of receptor at the intracellular sites from where they recycle to the cell surface. The effect of BFA was additive to the redistribution induced by insulin-like growth factors I and II and was observed in all human and rodent cell lines analyzed. BFA increased also the cell surface expression of the Mr 46,000 mannose 6-phosphate receptor but not of the transferrin receptor. The results indicate that BFA interferes with the transport of mannose 6-phosphate receptors and affects the endocytosis of lysosomal enzymes by increasing the number of receptors available for recycling to the cell surface.
authors.affiliation: Georg-August-Universität Göttingen, Biochemie II, Göttingen, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Damke
authors.forename: J
authors.initials: J
authors.lastname: Klumperman
authors.forename: K
authors.initials: K
authors.lastname: von Figura
authors.forename: T
authors.initials: T
authors.lastname: Braulke
mesh_terms: D000345:Affinity Labels; D000818:Animals; D000935:Antifungal Agents / Q000378:metabolism; D001692:Biological Transport; D020126:Brefeldin A; D002462:Cell Membrane / Q000378:metabolism; D006224:Cricetinae; D003432:Cross-Linking Reagents; D003517:Cyclopentanes / Q000494:pharmacology*; D004705:Endocytosis / Q000187:drug effects*; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007425:Intracellular Membranes / Q000378:metabolism; D008360:Mannosephosphates / Q000378:metabolism; D008715:Methionine / Q000378:metabolism; D017527:Receptor, IGF Type 2; D011956:Receptors, Cell Surface / Q000378:metabolism*; D017451:Receptors, Somatomedin; D013002:Somatomedins / Q000378:metabolism; D014168:Transferrin / Q000378:metabolism
chemical_list: D000345:Affinity Labels; D000935:Antifungal Agents; D003432:Cross-Linking Reagents; D003517:Cyclopentanes; D008360:Mannosephosphates; D017527:Receptor, IGF Type 2; D011956:Receptors, Cell Surface; D017451:Receptors, Somatomedin; D013002:Somatomedins; D014168:Transferrin; D020126:Brefeldin A; D008715:Methionine